title: Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes.
abstract: Bile salts have been hypothesized to mediate cytotoxicity by increasing membrane permeability to aqueous solutes. We examined whether submicellar bile salt concentrations affect model and native membrane permeability to small uncharged molecules such as water, urea, and ammonia. Osmotic water permeability (Pf) and urea permeability were measured in large unilamellar vesicles composed with egg yolk phosphatidylcholine (EYPC) +/- cholesterol (Ch) or rat liver microsomal membranes by monitoring self-quenching of entrapped carboxyfluorescein (CF). Ammonia permeability was determined utilizing the pH dependence of CF fluorescence. Submicellar bile salt concentrations did not significantly alter Pf of EYPC +/- Ch or rat liver microsomal membranes. At taurodeoxycholate (TDC) or tauroursodeoxycholate concentrations approaching those that solubilized membrane lipids, CF leakage occurred from vesicles, but Pf remained unchanged. Higher bile salt concentrations (0.5-2 mM TDC) did not alter Pf of equimolar EYPC/Ch membranes. The activation energy for transmembrane water flux was unchanged (12.1 +/- 1.2 kcal/mol for EYPC) despite the presence of bile salts in one or both membrane hemileaflets, suggesting strongly that bile salts do not form transmembrane pores that facilitate water flux. Furthermore, submicellar bile salt concentrations did not increase membrane permeability to urea or ammonia. We conclude that at submicellar concentrations, bile salts do not form nonselective convective channels that facilitate transmembrane transport of small uncharged molecules. These results suggest that bile salt-mediated transport of specific substrates, rather than nonselective enhancement of membrane permeability, underlies bile salt cytotoxicity for enterocytes and hepatocytes.
authors.affiliation: Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
authors.forename: A
authors.initials: A
authors.lastname: Albalak
authors.forename: M L
authors.initials: ML
authors.lastname: Zeidel
authors.forename: S D
authors.initials: SD
authors.lastname: Zucker
authors.forename: A A
authors.initials: AA
authors.lastname: Jackson
authors.forename: J M
authors.initials: JM
authors.lastname: Donovan
mesh_terms: D000641:Ammonia; D000818:Animals; D001647:Bile Acids and Salts / Q000494:pharmacology; D002151:Calorimetry; D004305:Dose-Response Relationship, Drug; D006002:Glycodeoxycholic Acid / Q000494:pharmacology; D007425:Intracellular Membranes / Q000378:metabolism*; D007700:Kinetics; D008027:Light; D008081:Liposomes; D008297:Male; D008823:Micelles; D008862:Microsomes, Liver / Q000378:metabolism*; D008954:Models, Biological; D008970:Molecular Weight; D010539:Permeability; D010713:Phosphatidylcholines; D051381:Rats; D017207:Rats, Sprague-Dawley; D012542:Scattering, Radiation; D012996:Solutions; D013655:Taurochenodeoxycholic Acid / Q000494:pharmacology; D013657:Taurodeoxycholic Acid / Q000494:pharmacology; D014508:Urea
chemical_list: D001647:Bile Acids and Salts; D008081:Liposomes; D008823:Micelles; D010713:Phosphatidylcholines; D012996:Solutions; D006002:Glycodeoxycholic Acid; D013655:Taurochenodeoxycholic Acid; D013657:Taurodeoxycholic Acid; C031655:ursodoxicoltaurine; D000641:Ammonia; D014508:Urea